JP2022530824A5 - - Google Patents
Info
- Publication number
- JP2022530824A5 JP2022530824A5 JP2021564730A JP2021564730A JP2022530824A5 JP 2022530824 A5 JP2022530824 A5 JP 2022530824A5 JP 2021564730 A JP2021564730 A JP 2021564730A JP 2021564730 A JP2021564730 A JP 2021564730A JP 2022530824 A5 JP2022530824 A5 JP 2022530824A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- expression cassette
- raav
- composition
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962840911P | 2019-04-30 | 2019-04-30 | |
| US62/840,911 | 2019-04-30 | ||
| US201962913401P | 2019-10-10 | 2019-10-10 | |
| US62/913,401 | 2019-10-10 | ||
| PCT/US2020/030493 WO2020223362A1 (en) | 2019-04-30 | 2020-04-29 | Compositions useful for treatment of pompe disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022530824A JP2022530824A (ja) | 2022-07-01 |
| JP2022530824A5 true JP2022530824A5 (cg-RX-API-DMAC7.html) | 2023-05-08 |
Family
ID=73029176
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564730A Pending JP2022530824A (ja) | 2019-04-30 | 2020-04-29 | ポンペ病の治療のために有用な組成物 |
| JP2021565001A Active JP7585233B2 (ja) | 2019-04-30 | 2020-04-29 | ポンペ病の治療のために有用な組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021565001A Active JP7585233B2 (ja) | 2019-04-30 | 2020-04-29 | ポンペ病の治療のために有用な組成物 |
Country Status (16)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018281280B2 (en) | 2017-06-07 | 2024-12-19 | Regeneron Pharmaceuticals, Inc. | Compositions and methods for internalizing enzymes |
| CN112040985A (zh) | 2018-02-07 | 2020-12-04 | 瑞泽恩制药公司 | 用于递送治疗性蛋白质的方法和组合物 |
| EP3793591A1 (en) | 2018-05-17 | 2021-03-24 | Regeneron Pharmaceuticals, Inc. | Anti-cd63 antibodies, conjugates, and uses thereof |
| JP2022552254A (ja) * | 2019-10-10 | 2022-12-15 | アミカス セラピューティックス インコーポレイテッド | バリアントigf2構築体 |
| EP4149519A4 (en) * | 2020-05-14 | 2024-06-12 | The Trustees of The University of Pennsylvania | COMPOSITIONS FOR THE TREATMENT OF POMPE DISEASE |
| CA3183153A1 (en) | 2020-06-17 | 2021-12-23 | Christian HINDERER | Compositions and methods for treatment of gene therapy patients |
| AU2022388800A1 (en) * | 2021-11-12 | 2024-06-27 | The Trustees Of The University Of Pennsylvania | Gene therapy for treatment of mucopolysaccharidosis iiia |
| NL2031676B1 (en) * | 2022-04-22 | 2023-11-07 | Univ Erasmus Med Ct Rotterdam | Gene therapy for Pompe Disease |
| WO2024003687A1 (en) * | 2022-06-28 | 2024-01-04 | Pfizer Inc. | Nucleic acids encoding acid alpha-glucosidase (gaa) and vectors for gene therapy |
| US20260216373A1 (en) * | 2023-01-13 | 2026-07-30 | Amicus Therapeutics, Inc. | Gene Therapy Constructs for the Treatment of Pompe Disease |
| CN116693633B (zh) * | 2023-02-21 | 2023-12-22 | 广州派真生物技术有限公司 | 腺相关病毒突变体及其应用 |
| WO2025171163A1 (en) * | 2024-02-06 | 2025-08-14 | Duke University | Compositions for and methods of treating lysosomal storage diseases |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1587923E (pt) * | 2003-01-22 | 2011-12-07 | Univ Duke | Construções melhoradas para a expressão de polipéptidos lisossomais |
| DE602005020745D1 (de) * | 2004-02-10 | 2010-06-02 | Zystor Therapeutics Inc | Saure alpha-glukosidase und fragmente davon |
| AU2007322123A1 (en) * | 2006-11-13 | 2008-05-29 | Biomarin Pharmaceutical Inc. | Methods for treating Pompe disease |
| DK2205737T3 (da) * | 2007-10-04 | 2013-05-21 | Santaris Pharma As | Mikromirer |
| WO2009137721A2 (en) * | 2008-05-07 | 2009-11-12 | Zystor Therapeutics, Inc. | Lysosomal targeting peptides and uses thereof |
| WO2010096369A1 (en) * | 2009-02-18 | 2010-08-26 | Amicus Therapeutics, Inc. | Mouse model for pompe disease and methods of use thereof |
| EP2628803A3 (en) | 2009-02-25 | 2014-01-01 | Cepheid | Methods of detecting lung cancer |
| US8785168B2 (en) * | 2009-06-17 | 2014-07-22 | Biomarin Pharmaceutical Inc. | Formulations for lysosomal enzymes |
| HRP20181315T1 (hr) | 2010-11-22 | 2018-10-19 | Amicus Therapeutics, Inc. | Nove signalne sekvence za poboljšanje ekspresije proteina i izlučivanja rekombinantnih enzima i drugih proteina |
| WO2012070014A2 (en) * | 2010-11-26 | 2012-05-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells |
| GB201103062D0 (en) * | 2011-02-22 | 2011-04-06 | Isis Innovation | Method |
| LT2714752T (lt) * | 2011-05-27 | 2018-03-12 | Amicus Therapeutics, Inc. | Nukreipiančių peptidų kopuliavimo ant rekombinantinių lizosominių fermentų būdai, skirti lizosominio kaupimo ligų gydymo pagerinimui |
| WO2013013019A2 (en) * | 2011-07-21 | 2013-01-24 | Alnylam Pharmaceuticals, Inc. | Lysosomal polypeptides, methods of making and using |
| CA2947466A1 (en) * | 2014-05-01 | 2015-11-05 | University Of Washington | In vivo gene engineering with adenoviral vectors |
| AU2016366549B2 (en) * | 2015-12-11 | 2022-11-10 | California Institute Of Technology | Targeting peptides for directing adeno-associated viruses (AAVs) |
| KR102618519B1 (ko) * | 2016-03-30 | 2023-12-28 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 재조합 산 알파-글루코시다제를 포함하는 제형 |
| EP3293260A1 (en) * | 2016-09-12 | 2018-03-14 | Genethon | Acid-alpha glucosidase variants and uses thereof |
| KR102617502B1 (ko) * | 2016-09-12 | 2023-12-26 | 제네똥 | 산-알파 글루코시다제 변이체 및 이의 용도 |
| EP3293259A1 (en) | 2016-09-12 | 2018-03-14 | Genethon | Acid-alpha glucosidase variants and uses thereof |
| WO2018178067A1 (en) * | 2017-03-27 | 2018-10-04 | Vrije Universiteit Brussel | Diaphragm-specific nucleic acid regulatory elements and methods and use thereof |
| JP2018198611A (ja) | 2018-08-03 | 2018-12-20 | ウニベルシダッド アウトノマ デ バルセロナ | 脂肪組織に形質導入するのに有用なアデノ随伴ウイルスベクター |
-
2020
- 2020-04-29 US US17/606,414 patent/US20220193261A1/en not_active Abandoned
- 2020-04-29 CA CA3134485A patent/CA3134485A1/en active Pending
- 2020-04-29 PH PH1/2021/552638A patent/PH12021552638A1/en unknown
- 2020-04-29 AU AU2020266829A patent/AU2020266829A1/en not_active Abandoned
- 2020-04-29 WO PCT/US2020/030493 patent/WO2020223362A1/en not_active Ceased
- 2020-04-29 BR BR112021021792A patent/BR112021021792A2/pt not_active IP Right Cessation
- 2020-04-29 CN CN202080048355.1A patent/CN114127275A/zh active Pending
- 2020-04-29 EP EP20799541.6A patent/EP3963063A4/en not_active Withdrawn
- 2020-04-29 JP JP2021564730A patent/JP2022530824A/ja active Pending
- 2020-04-29 KR KR1020217038223A patent/KR20220008280A/ko not_active Withdrawn
- 2020-04-29 EP EP20798851.0A patent/EP3980548A4/en not_active Withdrawn
- 2020-04-29 WO PCT/US2020/030484 patent/WO2020223356A1/en not_active Ceased
- 2020-04-29 US US17/606,410 patent/US20220193207A1/en not_active Abandoned
- 2020-04-29 SG SG11202111380VA patent/SG11202111380VA/en unknown
- 2020-04-29 PH PH1/2021/552637A patent/PH12021552637A1/en unknown
- 2020-04-29 BR BR112021021720A patent/BR112021021720A2/pt not_active IP Right Cessation
- 2020-04-29 TW TW109114314A patent/TW202100541A/zh unknown
- 2020-04-29 AU AU2020266552A patent/AU2020266552A1/en not_active Abandoned
- 2020-04-29 JP JP2021565001A patent/JP7585233B2/ja active Active
- 2020-04-29 MX MX2021013365A patent/MX2021013365A/es unknown
- 2020-04-29 KR KR1020217038231A patent/KR20220004696A/ko not_active Withdrawn
- 2020-04-29 SG SG11202111400TA patent/SG11202111400TA/en unknown
- 2020-04-29 CA CA3134523A patent/CA3134523A1/en active Pending
- 2020-04-29 CN CN202080049015.0A patent/CN114072515A/zh active Pending
- 2020-04-29 MX MX2021013364A patent/MX2021013364A/es unknown
-
2021
- 2021-10-20 CL CL2021002754A patent/CL2021002754A1/es unknown
- 2021-10-20 CL CL2021002755A patent/CL2021002755A1/es unknown
- 2021-10-24 IL IL287522A patent/IL287522A/en unknown
- 2021-10-24 IL IL287523A patent/IL287523A/en unknown
- 2021-11-29 CO CONC2021/0016200A patent/CO2021016200A2/es unknown
- 2021-11-29 CO CONC2021/0016198A patent/CO2021016198A2/es unknown
-
2025
- 2025-10-14 US US19/357,225 patent/US20260191993A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7707261B2 (ja) | 筋疾患の治療のための改変aavカプシドポリペプチド | |
| JP2022530833A5 (cg-RX-API-DMAC7.html) | ||
| JP7776477B2 (ja) | 転写調節要素及びその使用 | |
| KR102526711B1 (ko) | 고효율 게놈 편집을 위한 아데노-관련 바이러스 벡터 변이체 및 이의 방법 | |
| JP3487597B2 (ja) | 筋細胞内での発現のためのウイルス性組換え型ベクター | |
| US6033885A (en) | Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof | |
| ES2264123T3 (es) | Adenovirus recombinantes defectivos para la terapia genica de tumores. | |
| JP2022517174A5 (cg-RX-API-DMAC7.html) | ||
| JP2023526310A5 (cg-RX-API-DMAC7.html) | ||
| JP2022531861A5 (cg-RX-API-DMAC7.html) | ||
| KR20230084542A (ko) | 플라코필린 2 유전자 치료 방법 및 조성물 | |
| US20240002462A1 (en) | Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs | |
| JP2022553406A5 (cg-RX-API-DMAC7.html) | ||
| WO2023035687A1 (zh) | 用于治疗庞贝氏病的基因治疗构建体、药物组合物和方法 | |
| EP4509606A1 (en) | Nucleic acid construct for treating hereditary coagulation factor deficiency and use thereof | |
| JP2002533359A (ja) | 組換えアデノ随伴ウイルスベクターを用いる、心筋細胞への効率的かつ安定なインビボでの遺伝子移入 | |
| WO1999061034A1 (en) | Improved vectors | |
| JP2024514110A (ja) | 不整脈原性右心室心筋症に対する遺伝子療法 | |
| US20030035794A1 (en) | Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders | |
| WO2021230385A1 (en) | Method for treating muscular dystrophy by targeting utrophin gene | |
| US20170065685A1 (en) | Serca2 therapeutic compositions and methods of use | |
| JP2022554141A (ja) | 糖原病を治療するための組成物及び方法 | |
| CN112041437A (zh) | 用于恢复f8基因功能的腺相关病毒组合物和其使用方法 | |
| CN107073078A (zh) | 利用肝细胞生长因子和基质细胞衍生因子1α的用于预防或治疗外周动脉疾病的组合物 | |
| TW202337476A (zh) | 用於與肌肉萎縮蛋白有關之心肌病之基因療法組合物及治療 |